Nexeon Medsystems Inc (NXNN) to Post FY2017 Earnings of ($0.14) Per Share, Taglich Brothers Forecasts

Nexeon Medsystems Inc (OTCMKTS:NXNN) – Equities research analysts at Taglich Brothers issued their FY2017 earnings per share (EPS) estimates for Nexeon Medsystems in a research note issued to investors on Tuesday. Taglich Brothers analyst H. Halpern anticipates that the company will post earnings of ($0.14) per share for the year. Taglich Brothers has a “Speculative Buy” rating on the stock. Taglich Brothers also issued estimates for Nexeon Medsystems’ Q4 2017 earnings at ($0.03) EPS, Q1 2018 earnings at ($0.03) EPS, Q2 2018 earnings at ($0.03) EPS, Q3 2018 earnings at ($0.03) EPS, Q4 2018 earnings at ($0.04) EPS and FY2018 earnings at ($0.13) EPS.

Nexeon Medsystems (OTCMKTS NXNN) opened at $1.01 on Friday. The firm has a market cap of $27.50 and a PE ratio of -5.61. Nexeon Medsystems has a 1-year low of $0.40 and a 1-year high of $2.50.

TRADEMARK VIOLATION WARNING: This piece of content was first reported by Markets Daily and is the property of of Markets Daily. If you are accessing this piece of content on another publication, it was illegally copied and republished in violation of United States and international copyright legislation. The legal version of this piece of content can be read at https://www.themarketsdaily.com/2018/01/13/nexeon-medsystems-inc-nxnn-to-post-fy2017-earnings-of-0-14-per-share-taglich-brothers-forecasts.html.

Nexeon Medsystems Company Profile

Nexeon MedSystems, Inc is a bioelectronics company developing active medical devices for the treatment of cardiovascular disease. The Company’s developing technology solutions device including electronics, software, mechanical engineering, and material science, as well as pharmaceuticals, protein chemistry, and cell biology.

Receive News & Ratings for Nexeon Medsystems Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nexeon Medsystems and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply